Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

AC Immune (ACIU) Net Margin (2016 - 2026)

AC Immune has reported Net Margin over the past 9 years, most recently at 1322.7% for Q1 2026.

  • Quarterly Net Margin rose 59942.0% to 1322.7% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 1787.93% through Mar 2026, down 160984.0% year-over-year, with the annual reading at 1971.65% for FY2025, 178520.0% down from the prior year.
  • Net Margin was 1322.7% for Q1 2026 at AC Immune, up from 4252.37% in the prior quarter.
  • Over five years, Net Margin peaked at 21.59% in Q3 2024 and troughed at 4252.37% in Q4 2025.
  • The 4-year median for Net Margin is 1622.43% (2025), against an average of 1759.47%.
  • The largest YoY upside for Net Margin was 169052bps in 2025 against a maximum downside of -286327bps in 2025.
  • A 4-year view of Net Margin shows it stood at 346.36% in 2022, then tumbled by -301bps to 1389.09% in 2024, then plummeted by -206bps to 4252.37% in 2025, then skyrocketed by 69bps to 1322.7% in 2026.
  • Per Business Quant, the three most recent readings for ACIU's Net Margin are 1322.7% (Q1 2026), 4252.37% (Q4 2025), and 1688.82% (Q3 2025).